about
Patient relevant outcomes after total hip replacement. A comparison between different surgical techniquesMyocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesisBiological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review.Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee.Exercise and manual physiotherapy arthritis research trial (EMPART): a multicentre randomised controlled trialBaseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian rheumatology association database.Why do people with rheumatoid arthritis still die prematurely?Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methodsCardiovascular morbidity and mortality in rheumatoid arthritis.Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis.Interaction between smoking and HLA-DRB1*04 gene is associated with a high cardiovascular risk in Brazilian Amazon patients with rheumatoid arthritis.Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune diseaseFacet joint osteoarthritis and low back pain in the community-based populationEfficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study.Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study.Health burden in chronic disease: multimorbidity is associated with self-rated health more than medical comorbidity alone.Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologistsClinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales.Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in olmsted county, Minnesota.Long term safety of etanercept in elderly subjects with rheumatic diseases.Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndromeBaseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient registerMetabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study.Impact of knee osteoarthritis on health care resource utilization in a US population-based national sample.Mental and physical comorbid conditions and days in role among persons with arthritisCardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results.Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based studyHeritability of a skeletal biomarker of biological aging.Association of the Charlson comorbidity index with renal outcome and all-cause mortality in antineutrophil cytoplasmatic antibody-associated vasculitis.Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosusCo-morbidity in patients with early rheumatoid arthritis - inflammation mattersAggregate health burden and the risk of hospitalization in older persons post hip replacement surgery.Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, MinnesotaManagement of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies.Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis.The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.Rheumatoid factor mediates excess serum lipoprotein(a) for independent association with type 2 diabetes in men.
P2860
Q24803080-44549AF9-8D12-4793-95BC-3155744E3507Q24812557-44E03EC5-C8F3-4B46-B640-C681C968C07CQ24816745-200BFF65-8D9C-4D8E-BF6D-1F4191486093Q33346952-3EADD382-2803-4373-8212-7935DAAE44BEQ33400862-6F2D33CC-AFD9-4EC8-AAD7-A192E0939715Q33529391-8FF80629-B4A3-4CA7-B05D-10299458DC2CQ33697879-D2994D29-3131-4BC9-85F8-D8F7A0E9B8F4Q33774297-8CA1D75C-8C4B-453F-9F38-9FD1D2D808C9Q33806651-8C95B9C7-CCDA-4941-B0A6-0E31CBA09C6EQ34125171-39F28A29-4C57-4623-9A5D-6DD6E4556054Q34388610-F8CAF8FD-F1DD-41FC-B893-BF611A49EB36Q34477808-8BEC3D7D-CFB7-4164-9974-585B31E00278Q34496023-06171058-FD24-4612-8936-5EF1956A1D3CQ35520129-C2E924E9-4D49-4109-8A32-AFD65CA526CCQ35552077-D0C806A4-302C-4E4F-AE88-B4F58072022BQ35552382-9D1E4F74-AE84-4799-B0EF-176945399B98Q35553370-13758937-B14E-4DE4-89B4-28580B320484Q35553966-5933B287-FC6B-4A3E-A03E-97A2A9C2FFAEQ35579999-76C2DBC5-E92A-419C-BA4C-FE04E2DB6FB4Q35636875-F5CC6B40-6B51-4330-BE32-10E75A940233Q35636932-166F2E77-D02A-4B87-A5F3-C2FB355133FFQ35637343-737443F9-286E-43CF-B76C-2415F8A6700FQ35638342-FF89828E-5D5E-4963-B7AB-2AB240D4EC68Q35673136-57BE9FDB-1425-49E0-BC5A-41985D9AE01EQ35928751-CCEB9D2F-8943-4B04-BB95-A5FA28A6934AQ35929968-0200E122-451C-4BF0-969C-188EDA51414BQ36028729-8868D5B5-F1D7-49DD-BB9B-81CD0D50EF35Q36074289-4F33C363-0F46-4373-9A5F-95ECE46DF4C5Q36088564-20E6428D-7818-431D-A731-C96136B573C5Q36193742-CE8130D8-58DA-40A5-9C6C-A44471CDE4ACQ36277899-C7FCA26B-EAF9-44EF-965A-9E69B4FEE70EQ36513993-1199386D-ADE9-4E62-A80A-AD4616F89948Q36709365-098DAE88-9466-4378-B72F-49245FB2808DQ36915024-CF5C0A02-3A4A-4D37-86C1-469B28740338Q37058791-33186BCE-364F-40AB-9BD2-DDEE40867E80Q37163337-18D54ED7-D0A6-4267-A47C-7ABE8AAD86D8Q37169541-F640453C-BBF1-49E0-902B-CCC8E3F0B5BDQ37172521-5DE64A4A-5081-4E33-A447-1D0307DDF67EQ37356818-47BB6E5F-A1D6-46E5-920A-BC4459586610Q37680564-A4DE535A-4F70-4ADB-A9AB-F89D3CAC6C00
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Comorbidity in arthritis.
@en
type
label
Comorbidity in arthritis.
@en
prefLabel
Comorbidity in arthritis.
@en
P2093
P1476
Comorbidity in arthritis
@en
P2093
Crowson CS
Gabriel SE
O'Fallon WM
P304
P407
P577
1999-11-01T00:00:00Z